Upcoming Allied Market Research
Inotropic Agent Market

Inotropic Agent Market by Type (Positive Inotropic Drugs, Negative Inotropic Drugs, and Others), Indication (Heart Attack, Heart Failure, Angina, Arrhythmia, and Others), Route of Administration (Oral, Parenteral, and Others), End User (Hospitals, Specialty Centers, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028

Pages: NA
Sep 2022 | 512 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Inotropic Agent Market

Request Now !

Inotropic Agent Market Statistics 2028 -

Inotropic agent is a medicine responsible for changing the force of the heart's contractions. These agents are of two types, positive inotropic agent and negative inotropic agents. Positive inotropic agents strengthen the force of the heart resulting in an increased heartbeat. On the other hand, negative inotropic agents weaken the force of the heart causing a decrease in heartbeats. Both these types of inotropes are used in the treatment of various cardiovascular conditions, including hypertension, cardiomyopathy (congestive heart failure), arrhythmias (abnormal heart rhythms), angina (chest pain), and chronic heart failure.



COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the inotropic agent market.

Top Impacting Factors

Rise in prevalence of heart diseases and heart surgeries all across the globe is one of the factors that will drive the ionotropic agent market during the forecast period.

In addition, with a change in lifestyle, high number of people suffering from hypertension. Ionotropic agents are often used to control such conditions, which is influencing the inotropic agent market growth positively.

Negative inotropes weaken the contraction of the heart. Hence, they are useful in treating a variety of cardiac diseases such as abnormal heart rhythms, angina (chest pain), and chronic heart failure. With such a broad usage, these inotropes are expected to gain a significant share in the market, thus propelling the market growth.

However, novel inotropic agents in the market are losing their patents’ exclusivity. This can set a trend for the introduction of generic medicines, which is expected to impede the growth of original inotropic agents market.

Key Market Trends

North America acquires the largest share in the inotropic agent market, as the pharmaceutical organizations in this region are taking various initiatives to generate novel formulations of inotropic agents.

Asia-Pacific is anticipated to account for the largest market share during the forecast period, due to increase in cases of diabetes and hypertension along with rise in prevalence of cardiac diseases.

Some prominent players in the inotropic agents market are implementing different strategies, which include making acquisitions and launching new products. This is helping them consolidate their positions in the global inotropic agent market.

Moreover, a steep rise in availability of public funding for the development of inotropic agents is fueling the market. Some of the companies that dominate the inotropic agent market are Maybe Pharma Group Ltd., Janssen Pharmaceuticals, Inc., and Johnson and Johnson Services, Inc.

Key Benefits of the Report

  • This study presents the analytical depiction of the inotropic agent industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the inotropic agent market share.
  • The current market is quantitatively analyzed from 2020 to 2028 to highlight the inotropic agent market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Inotropic Agent Report

  • Which are the leading players active in the inotropic agent market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the inotropic agent market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is an inotropic agent?
  • What is the inotropic agent market prediction in the future?
  • What are the current trends and predicted trends?

Key Market Segments & Key Market Players

Segments Sub-segments
By Type
  • Positive Inotropic Drugs
  • Negative Inotropic Drugs
  • Others
By Indication
  • Heart Attack
  • Heart Failure
  • Angina
  • Arrhythmia
  • Others
Route of Administration
  • Oral
  • Parenteral
  • Others
End User
  • Hospitals
  • Specialty Centers
  • Others
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
Key Market Players GlaxoSmithKline Plc., Sanofi, Eli Lilly and Company, Covis Pharma, Mylan N.V., Pfizer Inc., Hikma Pharmaceuticals PLC., Fresenius Kabi USA., Baxter, Sun Pharmaceuticals Industries Ltd.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Flash Sale

Start reading ,This Report and over 13000+ more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now









Purchase Full Report of
Inotropic Agent Market

Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers